The pathogenesis of acute renal failure remains uncertain. From a clinical viewpoint the magnitude of the problem of nephrotoxic acute renal failure is now recognised as is the frequency of non-oliguric acute renal failure. Advances in patient management include the use of daily dialysis, lower heparin doses, single-needle dialysis, bicarbonate-base dialysis fluid, artificial kidneys with biocompatible membranes, H2 antagonists, and the use of soft silastic Tenckhoff catheters if peritoneal dialysis is the preferred form of therapy.
It is now ten years since I reviewed the subject of acute renal failure in Anaesthesia and Intensive Care. l During that period, there has been considerable improvement in patient management but no major advances in the understanding of the pathogenesis. In this manuscript, some of the changes which have occurred in the past ten years are examined. There is no attempt to outline a detailed plan of diagnosis and management or even to cover all controversial topics. Two recent publications on the subject provide details of experimental studies as well as clinical aspects of acute renal failure. 2 ,3 Acute renal failure due to drugs Nephrotoxicity due to drugs is an important cause of acute renal failure in the '80s, and oliguria may be absent in this group of patients. There are two means by which drugs can cause renal failure: direct nephrotoxicity and interstitial nephritis.
Aminoglycoside administration accounts for approximately 20070 of all acute renal failure, and 10 to 20070 of patients treated with aminoglycosides develop acute renal dysfunction due to direct nephrotoxicity. 4 The patients at risk are the elderly in whom serum creatinine determinations do not fully reveal the degree of reduced glomerular filtration rate, the diabetic patient, the jaundiced patient, the patient with unrecognised renal disease, and patients with systemic diseases. In fact, in all situations where acute renal failure may occur, the presence of these factors increases the risk.
The incidence of interstitial nephritis is probably grossly underestimated. A myriad of drugs may be responsible, notably penicillin derivatives and diuretics, but the diganosis can only be made by examination of renal tissue. Renal biopsy is not often undertaken in this difficult group of patients and the lack of a tissue diagnosis leads to underutilisation of the appropriate treatment which is withdrawal of the offending agent and corticosteroid therapy. lAMES M. HAYES Clinical clues to the presence of interstitial nephritis are gross haematuria, hyperchloraemic acidosis, eosinophilia, the absence of oliguria, rash, and eosinophils in the urinary sediment.
The widespread use of non-steroid antiinflammatory agents is often associated with a reduction in glomerular filtration rate, sodium retention, suppression of plasma renin activity and a tendency to hyperkalaemia. Refractory oedema states sometimes respond to withdrawal of such agents. Occasionally, more severe renal disease follows the use of nonsteroid anti-inflammatory agents with renal failure and proteinuria occurring. Indomethacin and naproxen therapy should be ceased in situations where there is a risk of acute renal impairment.
Cyclosporin A is an exciting new immunosuppressive agent but its use is almost invariably associated with some degree of nephrotoxicity and hypertension. Occasionally, acute reversible renal failure occurs. Rarely, a fatal form of acute renal failure occurs due to a thrombotic thrombocytopoenic purpura-like syndrome with thrombotic glomerular lesions and central nervous system involvement.
Acute renal failure due to rhabdomyolysis
Renal failure associated with rhabdomyolysis is characterised by severe hyperkalaemia and creatininaemia and marked hypocalcaemia. The entity has been widely recognised only in the past decade and is usually associated with intravenous narcotic abuse or alcoholism. 5 Obvious limb damage with muscle necrosis is usual, and surgical decompression to relieve ischaemia caused by compression of peripheral vessels by ·swollen muscle is often necessary. The usual diagnostic triad consists of an enormously raised serum creatine phosphokinase level, myoglobinuria and the presence of pigmented casts in the urinary sediment.
The renal failure is often associated with preservation of a good urinary output and the requirement for dialysis often lasts only a week or less. Hypercalcaemia is common in the recovery phrase. The prognosis for recovery of renal function is excellent and the major longterm disability involves the damaged limbs and often requires specialist rehabilitation. A hepatitis B screen to recognise Australian antigenaemia is especially important for the protection of staff.
Acute renal failure with abdominal sepsis
Nephritis is a well-recognised complication of bacterial endocarditis and infected atrioventricular shunts, so, on general principles, there is no good reason why it should not occur in patients with abdominal sepsis. The incidence of this disorder is unknown because of the general policy of not undertaking renal biopsy in patients who are considered to be suffering from acute renal failure to to acute tubular necrosis. The finding of microscopic or macroscopic haematuria, proteinuria and hypertension should alert one to the possibility of this diagnosis in a patient who develops renal failure associated with sepsis. The urinary sediment should be examined for red blood cell casts in such patients and renal biopsy considered, if the patient's management is likely to be altered by the histological findings. Hypocomplementaemia does not usually occur in this group of patients although it is the rule in patients with endocarditis and associated nephritis.
Proliferative glomerular lesions (mesangial, endocapillary and extracapillary) are found together with complement deposition. Immunoglobulin deposits are not usual. Patients who recover normal renal function have been observed to maintain stable and normal renal function for years, presumably due to complete healing of the glomerular lesions.
Non-o/iguric acute renal failure
The advent of more intensive monitoring of both clinical and biochemical parameters in patients with acute renal failure has led to the more common recognition of non-oliguric acute renal failure, the incidence being put as high as 59070 (54 of 92 patients) in one recent prospective study.6 Of these 54 patients, 36 were not oliguric throughout their entire hospital course, while 18 were initially oliguric for periods of 4 to 48 hours.
Factors, apart from improved recognition, in the high frequency of non-oliguric acute renal failure are an increased frequency of nephrotoxic antibiotic-induced acute renal failure and increased use of potent diuretics. The widespread use of central venous pressure monitoring ensures more adequate maintenance of intravascular volume which results in more patients with acute renal failure who would formerly have been oliguric now falling into the non-oliguric group.
Not surprisingly, patients with non-oliguric acute renal failure have lower urinary sodium concentrations, lower fractional excretions of sodium and higher urine-to-plasma ratios of urea nitrogen than found in oliguric patients. Measured glomerular filtration rates are higher in non-oliguric patients. The course of nonoliguric acute renal failure is associated with less severe renal failure and fewer and fewer complications than that of oliguric renal failure. 6 Duration of hospitalisation is shorter (22 versus 31 days), the need for dialysis is less (28070 versus 84070), and the mortality is less (26070 versus 50070). The incidence of gastrointestinal bleeding, septicaemia, metabolic acidosis and neurological abnormalities is significantly less in the nonoliguric patient.
Acute renal failure of the nephrotoxic type can be seen as a spectrum of clinical situations, with non-oliguric acute renal failure at one end and cortical necrosis at the other.
Patient management and dialysis therapy
Over a period of 13 years, 82 patients have been haemodialysed for acute renal failure in the Intensive Care Unit at St. Vincent's Hospital, Sydney. Thirty-nine (39) patients lived -a survival rate of 47070. Our current approach is to provide haemodialysis daily or at least five days per week. More frequent dialysis than the usual thrice-weekly dialysis used for stable patients with chronic renal failure allows for the intensive care patient's catabolic state and its biochemical consequences. It also permits the intravenous administration of the considerable volumes of fluid required to optimise the patient's nutritional status. Lesser morbidity and mortality from gastrointestinal bleeding has been observed in patients dialysed daily.7 Regional heparinisation has been abandoned and small intravenous loading doses of heparin, 500 to 1000 U, are used and the whole blood glass activated coagulation time (Hemochron (R)) is monitored. Additional doses of heparin are given if the Hemochron time falls below the equivalent of a Lee-White Anaesthesia and Intensive Care, Vol. 1 J, No. 4. November, 1983 clotting time of 20 minutes. Using this technique, clinically important bleeding related to anticoagulation for dialysis is extremely rare. On occasions no anticoagulant at all is used.
'Single needle' dialysis (e.g. via a large-bore subclavian venous catheter) allows rapid access to the patient's circulation but is not able to provide blood flow rates of the order of 200 mllmin. External shunts provide better flow rates, are less likely to become dislodged and, perhaps, are less likely to become infected. However, for the patient with chronic renal failure undergoing long-term haemodialysis therapy, single needle dialysis is useful when vascular access has failed. One is able to avoid peritoneal dialysis and the need for an external shunt which sacrifices vessels. The high return pressure encountered when using a single needle device leads to obligatory ultrafiltration. This is usually desirable but on occasions the resulting fluid loss may need total or partial replacement.
Arteriovenous haemofiltration is likely to find a valuable place in the management of volume overloaded patients with or without renal failure.
If the patient is hypotensive or has cardiac arrthymias, biocarbonate dialysis is available and allows one to avoid the unwanted cardiac effects of acetate-based dialysis concentrate. 8 In such patients, it may also be desirable to avoid cuprophane membranes and to use an artifical kidney with a cellulose acetate ('biocompatible') membrane. This reduces the risk of pulmonary complications secondary to complement activation and sequestration of white cells in the lungs. 9 The cellulose acetate membranes also have the high ultrafiltration characteristics that are frequently required.
The administration of large amounts of intragastric antacids should be avoided in patients who are being vigorously volume depleted for pulmonary or other reasons. On occasions, these substances impact on the right side of the colon and can produce bowel obstruction and bowel necrosis. The use of the H2 antagonists cimetidine and ranitidine should provide control of gastric pH and reduce the incidence of bleeding from gastric erosions.
If peritoneal dialysis is preferred, surgical placement of a soft silastic Tenckhoff catheter* • Quinton Instrument Company. in the operating room is the optimum therapy. Hard peritoneal catheters should rarely be used as leakage around the catheter predisposes to infection and poor returns of dialysate are more common. Exchanges should commence in the operating theatre to prevent blockage due to clot and heparin (1000 U/2 litres) should be added to the dialysis fluid for the first 48-72 hours. If ultrafiltration is a major objective, then haemodialysis is more reliable.
Continuous ambulatory peritoneal dialysis (CAP D) utilising only 5 x 2 litre exchanges daily can be instituted for acute renal failure after the initial problems of hyperkalaemia, acidosis and fluid overload have been dealt with. Automated cycling devices also have a role to play providing that nursing staff have mastered their use. They can be labour conservative. If peritoneal dialysis is used, the protein loss, approximately 2 grams/litre, in the peritoneal returns needs to be considered when evaluating the patient's nutritional status. If peritonitis occurs, the protein loss increases. Amino acid loss amounts to at least a gram daily. Peritoneal dialysis can also be used to administer intraperitoneal antibiotics.
